Blackstone buys $1.5B worth of logistics centers | Ohio police race through anti-overdose drug supply | Apollo Global reportedly in talks to acquire CHS’ assets | Mylan CEO says company could have anticipated consumer concern over price hike From: Becker's…
Supply Chain Report
Supply chain salaries to increase nearly 3% in 2017 | Ice maker, sinks linked to UW Medical Center Legionnaires’ outbreak | Weighing the cost of care: How hospitals accommodate obese patients | Mylan CEO to explain EpiPen prices at Sept.…
Mayo’s head of supply chain names a problematic underinvestment | Indiana Blood Center pleads for O-negative donations | Dartmouth-Hitchcock to lay off up to 460 | 4 quotes from supply chain leaders on improving physician engagement From: Becker's Supply Chain…
EpiPen prescriptions spike despite controversy | What’s in Allegan’s new social contract? | A scary twist on opioids: 6 things to know about carfentanil | 110 physician leaders to know From: Becker's Supply Chain Report <editorial@beckershealthcare.com> Subject: EpiPen prescriptions spike…
What’s the cost of discarding unused surgical supplies? | Mylan paired executive pay with profit targets: 7 things to know | How much hand sanitizer is enough? | The pervasiveness of nurse bullying: 7 key thoughts From: Becker's Supply Chain…
Advertisement
Nestlé to acquire medical device company Phagenesis | Electrical fire forces Fla. hospital to evacuate 209 patients | Study: Pricey drug-coated stents don’t outperform conventional versions | 4 latest FDA approvals From: Becker's Supply Chain Report <editorial@beckershealthcare.com> Subject: Nestlé to…
Senators deem Mylan’s generic EpiPen a temporary solution | MD Anderson points to Epic implementation for 77% drop in adjusted income | The rise of the unbranded drug ad | Roche’s Zika test earns FDA emergency use authorization From: Becker's…
11 drugmakers with highest profit margins | DMC’s sterile processing issues date back 10 years | 4 more Mylan price hikes | 77 rural hospital closures, state by state From: Becker's Supply Chain Report <editorial@beckershealthcare.com> Subject: 11 drugmakers with highest…
EpiPens priced up to $700, controversy ensues | Clinton vs. Trump: 16 quotes on healthcare from the presidential candidates | Premier reports 13% net revenue increase in Q4 | FDA: Drug companies abuse citizen petitions to block generic competition From:…
Type O blood shortage hits the Pacific Northwest | Aetna’s threat to DOJ: 7 things to know | 10 healthcare supply chain management apps to know | 10 most interesting, challenging issues facing CEOs From: Becker's Supply Chain Report <editorial@beckershealthcare.com>…